Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Cumberland Pharmaceuticals Inc (CPIX)
NASDAQ:CPIX
RESEARCH TOOLSreports
Holding CPIX?
Track your performance easily
Earnings Data
Report Date
Mar 11, 2025TBA Not Confirmed
Period Ending
2024 (Q4)Consensus EPS Forecast
―Last Year’s EPS
-$0.44Same Quarter Last Year
Based on 0 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Nov 07, 2024
|% Change Since: 89.17%
|Next Earnings Date:Mar 11, 2025
Earnings Call Sentiment|Neutral
Cumberland Pharmaceuticals demonstrated solid performance with Kristalose and Sancuso, coupled with promising international and clinical development efforts. However, Vibativ's challenges due to external factors and a net loss in Q3 indicate areas needing improvement.Company Guidance
During the third quarter of 2024 earnings call for Cumberland Pharmaceuticals, the executives provided several key financial metrics and updates. The company reported $9.1 million in net revenue for the quarter with significant contributions from their FDA-approved brands, including $3.6 million from Kristalose, $2.6 million from Sancuso, $1.3 million from Caldolor, and $1 million from Vibativ. The quarter was impacted by shipment delays due to Hurricane Helene, which also led to an unusual amount of product returns affecting Vibativ sales. The balance sheet showed $77 million in total assets, $17.5 million in cash and investments, total liabilities of $52 million, and $25 million in shareholders' equity. The gross margin improved to 85%, and the company reported a net loss of $1.5 million, with an adjusted loss of $0.26 million. Despite these challenges, Cumberland remains optimistic about their brand performance, particularly with Kristalose's expanded Medicaid coverage and international growth opportunities for Vibativ. The company is also advancing several clinical programs and new product development initiatives, including new treatments for delirium and GI imaging, supported by collaborations and partnerships.Strong Performance of Kristalose
Kristalose generated $3.6 million in Q3 with significant Medicaid coverage expansion in states like Virginia, Louisiana, and Maine, contributing to its strong performance.
Positive Impact of Sancuso Initiatives
Sancuso revenue reached $2.6 million in Q3, with new patient-oriented programs and expanded oncology sales division supporting growth.
Caldolor's Clinical Data Publication
A new study demonstrated Caldolor's reduced incidence of adverse drug reactions, providing a potential for improved patient care and healthcare savings.
International Expansion for Vibativ
Vibativ received approval in Saudi Arabia with launch plans underway, indicating international growth potential.
CET Advancements in New Treatments
CET concluded a successful Phase II trial for a new delirium treatment and partnered with a corporation for a new GI imaging product.
Financial Stability and Shareholder Initiatives
Cumberland maintained $17.5 million in cash and $52 million in liabilities, with ongoing share repurchase programs.
---
CPIX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
CPIX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Nov 07, 2024 | $1.20 | $1.19 | -0.83% |
| Aug 06, 2024 | $1.50 | $1.48 | -1.33% |
| May 07, 2024 | $1.58 | $1.67 | +5.70% |
| Mar 05, 2024 | $2.00 | $1.94 | -3.00% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Cumberland Pharmaceuticals Inc (CPIX) report earnings?
Cumberland Pharmaceuticals Inc (CPIX) is schdueled to report earning on Mar 11, 2025, TBA Not Confirmed.
What is Cumberland Pharmaceuticals Inc (CPIX) earnings time?
Cumberland Pharmaceuticals Inc (CPIX) earnings time is at Mar 11, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CPIX EPS forecast?
Currently, no data Available
---